| 物质名称 | CAS登记号 | 物质唯一标识 | 分子式 | 异名/同义词 |
|---|---|---|---|---|
| BEVACIZUMAB | 216974-75-3 | 2S9ZZM9Q9V | BEVACIZUMAB-NWGD JOBEVNE 12-IGG1 AVASTIN BEVACIZUMAB BEVACIZUMAB (AVASTIN) BEVACIZUMAB [EMA EPAR] BEVACIZUMAB [JAN] BEVACIZUMAB [MART.] BEVACIZUMAB [MI] BEVACIZUMAB [PURPLE BOOK CDER] BEVACIZUMAB [USAN] BEVACIZUMAB [VANDF] BEVACIZUMAB, LICENSE HOLDER UNSPECIFIED BEVACIZUMAB [WHO-DD] IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF .GAMMA.-CHAIN ANTI-HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF LIGHT CHAIN, DIMER PF-06439535 [WHO-DD] RG-435 RHUMAB- RO-4876646 USP MAB 002, MONOCLONAL IGG1 [USP-RS] BEVACIZUMAB [INN] LY 01008 LY 01008 [WHO-DD] LY 01008(BIOSIMILAR OF BEVACIZUMAB) LY-01008 BEVACIZUMAB BIOSIMILAR (FKB-238) FKB 238 [WHO-DD] FKB-238 BEVACIZUMAB BETA BEVACIZUMAB BETA [WHO-DD] BEVACIZUMAB BETA [INN] Q-1101 Q1101 QL-1101 (BIOSIMILAR OF BEVACIZUMAB) BEVACIZUMAB BIOSIMILAR (CT-P16) BEVACIZUMAB-ADCD CT-16 CT-P16 CT-P16 (BIOSIMILAR OF BEVACIZUMAB) FKB238 ALYMSYS BEVACIZUMAB-MALY BEVZ-92 BEVZ92 BEVACIZUMAB BIOSIMILAR (AMNEAL PHARMACEUTICALS) BEVACIZUMAB BIOSIMILAR (MABXIENCE) BEVACIZUMAB MALY [WHO-DD] BEVAX MB-02 MB02 OYAVAS ABP-215 BEVACIZUMAB BIOSIMILAR (ABP-215) BEVACIZUMAB BIOSIMILAR (AMGEN) BEVACIZUMAB-AWWB BEVACIZUMAB-AWWB [PURPLE BOOK CDER] BEVACIZUMAB AWWB [WHO-DD] MVASI BEVACIZUMAB BIOSIMILAR (PF-06439535) BEVACIZUMAB BIOSIMILAR (PFIZER) BEVACIZUMAB-BVZR BEVACIZUMAB BVZR [WHO-DD] PF-06439535 ZIRABEV BEVACIZUMAB BIOSIMILAR - SHANGHAI HENLIUS BIOTECH HLX 04 [WHO-DD] HLX-04 HLX04 HLX04-O HLX04-O (RECOMBINANT ANTI-VEGF HUMANIZED MONOCLONAL ANTIBODY OPHTHALMIC INJECTION) AVZIVI BAT 1706 [WHO-DD] BAT-1706 BAT-1706 (BIOSIMILAR OF BEVACIZUMAB) BEVACIZUMAB BIOSIMILAR-INNOVENT BIOLOGICS BYVASDA IBI-305 IBI305 BAT1706 BEVACIZUMAB-TNJN AVA-1 BS-503 BS-503A BEVACIZUMAB BIOSIMILAR (GP-2019) BI 695502 [WHO-DD] BI-695502 BI695502 CT16 CTP-16 CTP16 VEGZELMA GP-2019 GP2019 |